SUZETRIGINE showed limited benefit for cancer-related bone pain in three patients with metastatic spinal disease.
has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) )>*]:pointer-events-auto supports ...
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the precision and comfort of cancer therapy. Designed by a team of researchers ...
For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 hours, according to ...
“Cancer wasn’t even on our radar,” Alana McArthur tells PEOPLE ...